Primary prophylaxis of febrile neutropenia using long-acting granulocyte colony-stimulating factors in female patients receiving dose-dense biweekly chemotherapy in the clinical routine.

被引：0
|
作者：
Kurbacher, Christian M. [1 ]
Kurbacher, A. Tabea [1 ]
Monreal, Katja [1 ]
Schweitzer, Claudia [1 ]
Sperling, Sandra [1 ]
Kolberg, Gabriele [1 ]
Kurbacher, Jutta A. [1 ]
机构：
[1] Gynecol Ctr Bonn Friedenspl, Bonn, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e20693
引用
收藏
页数：1
相关论文
共 50 条
  • [41] The effectiveness and safety of same-day versus next-day administration of long-acting granulocyte colony-stimulating factors for the prophylaxis of chemotherapy-induced neutropenia: a systematic review
    Lyman, Gary H.
    Allcott, Kim
    Garcia, Jacob
    Stryker, Scott
    Li, Yanli
    Reiner, Maureen T.
    Weycker, Derek
    SUPPORTIVE CARE IN CANCER, 2017, 25 (08) : 2619 - 2629
  • [42] Side effects of using granulocyte-colony stimulating factors as prophylaxis of febrile neutropenia in cancer patients: A systematic review
    Lapidari, Pietro
    Vaz-Luis, Ines
    Di Meglio, Antonio
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2021, 157
  • [43] Risk of chemotherapy-induced febrile neutropenia in intermediate-risk regimens: Clinical and economic outcomes of granulocyte colony-stimulating factor prophylaxis
    Aslam, Saad
    Li, Edward
    Bell, Elizabeth
    Lal, Lincy
    Anderson, Amy J.
    Peterson-Brandt, Jesse
    Lyman, Gary
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2023, 29 (02): : 128 - 138
  • [44] COST-EFFECTIVENESS AND COST-UTILITY OF GRANULOCYTE COLONY-STIMULATING FACTORS IN THE PRIMARY PROPHYLAXIS OF CHEMOTHERAPY INDUCED FEBRILE NEUTROPENIA (FN) IN BREAST CANCER PATIENTS IN GREECE: A COMPARATIVE ANALYSIS
    Kourlaba, G.
    Palaka, E.
    Papagiannopoulou, V
    Maniadakis, N.
    VALUE IN HEALTH, 2014, 17 (07) : A633 - A633
  • [45] Current practice of prophylaxis with granulocyte colony-stimulating factors for preventing chemotherapy-induced neutropenia in breast cancer patients in Spain
    Marina, J.
    Carabantes, F. J.
    de Romani, S. Escriva
    Pernas, S.
    Cantos, B.
    Caranana, V.
    Llorca, C.
    Vazquez, F.
    Ciruelos, E.
    Menjon, S.
    EJC SUPPLEMENTS, 2009, 7 (02): : 181 - 181
  • [46] Prophylaxis of infection using granulocyte colony-stimulating factors or antibiotics in patients receiving myelosupressive chemotherapy for Hodgkin lymphoma. What is the evidence?
    Herbst, C.
    Naumann, F.
    Knauel, J.
    Bohlius, J.
    Weingart, O.
    Engert, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 58 - 58
  • [47] Effectiveness of Prophylaxis with Granulocyte Colony-Stimulating Factor Among Cancer Patients Receiving Myelosuppressive Chemotherapy in US Clinical Practice
    Richert-Boe, Kathryn
    Lamerato, Lois
    Lyman, Gary H.
    Kaur, Manpreet
    Shah, Neel
    Lawrence, Tatiana
    Sundaresan, Devi
    Silvia, Amanda
    Hanau, Ahuva
    Weycker, Derek
    BLOOD, 2019, 134
  • [48] Systematic Review and Meta-analysis of Short-versus Long-Acting Granulocyte Colony-Stimulating Factors for Reduction of Chemotherapy-Induced Febrile Neutropenia (vol 35, pg 1816, 2018)
    Cornes, Paul
    Gascon, Pere
    Chan, Stephen
    Hameed, Khalid
    Mitchell, Catherine R.
    Field, Polly
    Latymer, Mark
    Arantes, Luiz H., Jr.
    ADVANCES IN THERAPY, 2018, 35 (11) : 1830 - 1830
  • [49] Primary Granulocyte Colony-Stimulating Factor Prophylaxis During the First Two Cycles Only or Throughout All Chemotherapy Cycles in Patients With Breast Cancer at Risk for Febrile Neutropenia
    Aarts, Maureen J.
    Peters, Frank P.
    Mandigers, Caroline M.
    Dercksen, M. Wouter
    Stouthard, Jacqueline M.
    Nortier, Hans J.
    van Laarhoven, Hanneke W.
    van Warmerdam, Laurence J.
    van de Wouw, Agnes J.
    Jacobs, Esther M.
    Mattijssen, Vera
    van der Rijt, Carin C.
    Smilde, Tineke J.
    van der Velden, Annette W.
    Temizkan, Mehmet
    Batman, Erdogan
    Muller, Erik W.
    van Gastel, Saskia M.
    Borm, George F.
    Tjan-Heijnen, Vivianne C. G.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (34) : 4290 - U20
  • [50] NUMBER NEEDED TO TREAT AND COST UTILITY ANALYSIS OF GRANULOCYTE-COLONY STIMULATING FACTORS FOR PRIMARY PROPHYLAXIS OF CHEMOTHERAPY INDUCED FEBRILE NEUTROPENIA IN DLBCL PATIENTS IN THE NETHERLANDS
    Lugtenburg, E.
    Levin, M. D.
    Somers, L.
    HAEMATOLOGICA, 2014, 99 : 698 - 699
12345